Kyxata availability in Atlanta, GA

Looking for Kyxata in Atlanta? FindRx checks live shelf stock at pharmacies across Atlanta and the wider Georgia area, so you don't have to call around.

Generic: Carboplatin.

Search live stock in Atlanta
29 products tracked
22 unavailable
4 limited availability
3 available

Kyxata is on the FDA drug shortage list · last updated Aug 18, 2026

Get an alert when Kyxata is back in stock near Atlanta

26 of 29 tracked Kyxata products are in short supply right now. We watch pharmacy shelves so you don't have to keep calling.

What's in shortage — Kyxata products

Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-6)
UNAVAILABLE
Teyro Labs
Reason: Discontinuation of the manufacture of the drug
Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug
Updated Aug 18, 2026
Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-7)
UNAVAILABLE
Teyro Labs
Reason: Discontinuation of the manufacture of the drug
Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug
Updated Aug 18, 2026
Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-3)
UNAVAILABLE
Teyro Labs
Reason: Discontinuation of the manufacture of the drug
Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug
Updated Aug 18, 2026
Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-1)
UNAVAILABLE
Teyro Labs
Reason: Discontinuation of the manufacture of the drug
Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug
Updated Aug 18, 2026
Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-33)
UNAVAILABLE
Accord Healthcare Inc.
Reason: Discontinuation of the manufacture of the drug
Estimated recovery: TBD; NDC is non-exempt
Updated Aug 17, 2026
Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-34)
UNAVAILABLE
Accord Healthcare Inc.
Reason: Requirements related to complying with good manufacturing practices
Estimated recovery: TBD; NDC is non-exempt
Updated Aug 17, 2026
Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-31)
UNAVAILABLE
Accord Healthcare Inc.
Reason: Discontinuation of the manufacture of the drug
Discontinuation of the manufacture of the drug
Updated Aug 17, 2026
Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4246-01)
UNAVAILABLE
Teva Pharmaceuticals USA, Inc.
Reason: Other
Estimated recovery: September 2026
Updated Aug 17, 2026
Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4244-01)
UNAVAILABLE
Teva Pharmaceuticals USA, Inc.
Reason: Other
Estimated recovery: October 2026
Updated Aug 17, 2026
Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4248-01)
UNAVAILABLE
Teva Pharmaceuticals USA, Inc.
Reason: Other
Estimated recovery: February 2027
Updated Aug 17, 2026
Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-12)
UNAVAILABLE
Accord Healthcare Inc.
Reason: Requirements related to complying with good manufacturing practices
Estimated recovery: TBD; NDC is non-exempt
Updated Aug 17, 2026
Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-339-50)
UNAVAILABLE
Hospira, Inc., a Pfizer Company
Reason: Other
Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay
Updated Aug 7, 2026
Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-262-05)
UNAVAILABLE
Hospira, Inc., a Pfizer Company
Reason: Other
Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay
Updated Aug 7, 2026
Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-339-18)
UNAVAILABLE
Hospira, Inc., a Pfizer Company
Reason: Demand increase for the drug
Next Delivery: February 2027; Estimated Recovery: March 2027
Updated Aug 7, 2026
Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-150-05)
UNAVAILABLE
Hospira, Inc., a Pfizer Company
Reason: Other
Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay
Updated Aug 7, 2026
Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) (NDC 61703-600-05)
UNAVAILABLE
Hospira, Inc., a Pfizer Company
Reason: Other
Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
Updated Aug 7, 2026
Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-339-22)
UNAVAILABLE
Hospira, Inc., a Pfizer Company
Reason: Other
Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
Updated Aug 7, 2026
Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-360-18)
UNAVAILABLE
Hospira, Inc., a Pfizer Company
Reason: Other
Next Delivery: February 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay
Updated Aug 7, 2026
Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) (NDC 61703-339-56)
UNAVAILABLE
Hospira, Inc., a Pfizer Company
Reason: Other
Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay
Updated Aug 7, 2026
Carboplatin, Injection, 450 mg/45 mL (NDC 55150-335-01)
UNAVAILABLE
Eugia US LLC
Reason: Demand increase for the drug
On backorder. Recovery: TBD. Check wholesalers for inventory
Updated Aug 6, 2026
Carboplatin, Injection, 10 mg/1 mL (NDC 63323-172-60)
UNAVAILABLE
Fresenius Kabi USA, LLC
Reason: Delay in shipping of the drug
Next release November 2026. Check wholesalers for inventory.
Updated Aug 4, 2026
Carboplatin, Injection, 50mg/5mL (NDC 54288-164-01)
UNAVAILABLE
Gland Pharma Limited
Reason: Discontinuation of the manufacture of the drug
Discontinued; Distributed by BPI Labs, LLC
Updated Jul 22, 2026
Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4239-01)
LIMITED
Teva Pharmaceuticals USA, Inc.
Reason: Other
Estimated recovery: December 2028
Updated Aug 17, 2026
Carboplatin, Injection, 450mg/45mL (NDC 54288-166-01)
LIMITED
Gland Pharma Limited
Reason: Demand increase for the drug
Estimated recovery: end of June 2026; Distributed by BPI Labs, LLC
Updated Jul 22, 2026
Carboplatin, Injection, 150mg/15mL (NDC 54288-165-01)
LIMITED
Gland Pharma Limited
Reason: Demand increase for the drug
Estimated recovery: end of August 2026; Distributed by BPI Labs, LLC
Updated Jul 22, 2026
Carboplatin, Injection, 600 mg/65 mL (NDC 54288-167-01)
LIMITED
Gland Pharma Limited
Reason: Demand increase for the drug
Distributed by BPI Labs, LLC
Updated Jul 22, 2026
Carboplatin, Injection, 600 mg/60 mL (NDC 55150-386-01)
AVAILABLE
Eugia US LLC
Check wholesalers for inventory
Updated Aug 6, 2026
Kyxata, Injection, 500 mg/50 mL (10 mg/mL) (NDC 83831-142-50)
AVAILABLE
Avyxa Pharma, LLC
Updated Aug 4, 2026
Kyxata, Injection, 80 mg/8 mL (10 mg/mL) (NDC 83831-141-08)
AVAILABLE
Avyxa Pharma, LLC
Updated Aug 4, 2026

How FindRx works in Atlanta

1. Search your medication
Tell us what you're picking up — we'll scan stock at pharmacies across Atlanta and nearby Georgia.
2. See who has it
Live availability at chains and independents, with distance and last-checked time — no phone calls.
3. Get restock alerts
If nobody in Atlanta has it today, we'll email or text you the moment a shelf restocks.

Kyxata availability in nearby cities

Nashville, TNCharlotte, NCJacksonville, FLLouisville, KYMemphis, TNRaleigh, NCKyxata near me →

Other shortages people are tracking

AdderallLidocaine HydrochlorideAccuprilKetorolac TromethamineNaropinFurosemidePrecedexMidazolam HydrochlorideAtropine SulfateMarcaine With Epinephrine

FindRx is a medication availability service — we track which pharmacies have products in stock and route you to them. We are not a pharmacy, we don't sell or dispense medication, and nothing on this page is medical advice. Shortage details come from the FDA Drug Shortages list and manufacturer updates; local stock changes hour to hour, so confirm with the pharmacy at pickup. Questions about whether a medication is right for you belong with your prescriber or pharmacist.